Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

TBP

Tetra Bio Pharma (TBP)

Tetra Bio Pharma Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:TSX:TBP
DatumZeitQuelleÜberschriftSymbolFirma
07/03/202314h01PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - TBPTSX:TBPTetra Bio Pharma Inc
07/03/202313h59PR Newswire (Canada)IIROC Trading Halt - TBPTSX:TBPTetra Bio Pharma Inc
11/02/202300h27PR Newswire (Canada)Tetra Bio-Pharma Announces Listing to OTCPink MarketTSX:TBPTetra Bio Pharma Inc
11/02/202300h27PR Newswire (US)Tetra Bio-Pharma Announces Listing to OTCPink MarketTSX:TBPTetra Bio Pharma Inc
22/12/202213h41PR Newswire (Canada)REDUVO™ Marketing Approval on the Right PathTSX:TBPTetra Bio Pharma Inc
22/12/202213h41PR Newswire (US)REDUVO™ Marketing Approval on the Right PathTSX:TBPTetra Bio Pharma Inc
06/12/202213h00PR Newswire (US)Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with FavipiravirTSX:TBPTetra Bio Pharma Inc
06/12/202213h00PR Newswire (Canada)Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with FavipiravirTSX:TBPTetra Bio Pharma Inc
29/11/202213h00PR Newswire (US)Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003TSX:TBPTetra Bio Pharma Inc
29/11/202213h00PR Newswire (Canada)Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003TSX:TBPTetra Bio Pharma Inc
18/11/202218h23PR Newswire (Canada)Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug SubmissionTSX:TBPTetra Bio Pharma Inc
18/11/202218h23PR Newswire (US)Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug SubmissionTSX:TBPTetra Bio Pharma Inc
27/10/202219h57PR Newswire (US)Tetra Bio-Pharma Inc. Announces Second Closing of Financing with Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
27/10/202219h57PR Newswire (Canada)Tetra Bio-Pharma Inc. Announces Second Closing of Financing with Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
11/10/202213h42PR Newswire (US)Tetra and Prepaire Jointly Apply to BARDA for FundingTSX:TBPTetra Bio Pharma Inc
11/10/202213h42PR Newswire (Canada)Tetra and Prepaire Jointly Apply to BARDA for FundingTSX:TBPTetra Bio Pharma Inc
08/09/202213h44PR Newswire (Canada)Tetra Bio-Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
08/09/202213h44PR Newswire (US)Tetra Bio-Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
06/09/202215h28PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - TBPTSX:TBPTetra Bio Pharma Inc
06/09/202215h27PR Newswire (Canada)IIROC Trade Resumption - TBPTSX:TBPTetra Bio Pharma Inc
06/09/202215h13PR Newswire (Canada)Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 PatientsTSX:TBPTetra Bio Pharma Inc
06/09/202215h13PR Newswire (US)Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 PatientsTSX:TBPTetra Bio Pharma Inc
06/09/202214h43PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - TBPTSX:TBPTetra Bio Pharma Inc
06/09/202214h41PR Newswire (Canada)IIROC Trading Halt - TBPTSX:TBPTetra Bio Pharma Inc
12/08/202204h19PR Newswire (US)Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
12/08/202204h19PR Newswire (Canada)Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue OceanTSX:TBPTetra Bio Pharma Inc
10/08/202212h30PR Newswire (Canada)Tetra Bio-Pharma Announces Positive Preclinical Results of ARDS-003, a Novel Therapeutic for Sepsis and Viral InfectionsTSX:TBPTetra Bio Pharma Inc
10/08/202212h30PR Newswire (US)Tetra Bio-Pharma Announces Positive Preclinical Results of ARDS-003, a Novel Therapeutic for Sepsis and Viral InfectionsTSX:TBPTetra Bio Pharma Inc
12/07/202213h30PR Newswire (Canada)Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription DrugTSX:TBPTetra Bio Pharma Inc
12/07/202213h30PR Newswire (US)Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription DrugTSX:TBPTetra Bio Pharma Inc
 Showing the most relevant articles for your search:TSX:TBP